Coronavirus: Five skin conditions linked to COVID-19 after - 9News Careers. They were found on hands and feet, showing up as red or purple spots caused by bleeding under the skin. (b) haematoxylineosin, original magnification 20. Washrawirul C, Triwatcharikorn J, Phannajit J, Ullman M, Susantitaphong P, Rerknimitr P. J Eur Acad Dermatol Venereol. Int J Infect Dis. The authors have no conflicts of interest to declare. 2022 Mar 15;10(3):624. doi: 10.3390/microorganisms10030624. We do not endorse non-Cleveland Clinic products or services. Bookshelf While home remedies are safe for most people, its a good idea to check with your healthcare provider before trying some of the following options. How do dermatologists treat pityriasis rosea? Variable dermatological manifestations including acral erythema, urticaria, vasculitis, vesicular or pustular eruptions, maculopapular rash have all been reported during the course of COVID19. Use of this site constitutes acceptance of our If you have pityriasis rosea, you dont have to avoid any foods or drinks. J Formos Med Assoc. ", The 29 Best Valentines Day Gifts for the Men in Your Life. Nevertheless, the incidence of skin reactions after mRNA vaccinations was low. J Formos Med Assoc. "It looks very different.". The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). The mechanisms behind these COVID-19-related symptoms remain unclear. The authors of one 2014 case report of a 71-year-old man who suffered from pityriasis rosea one month after receiving an influenza vaccine concluded that "altered immunity" could result in reactivation of HHV-6 and/or HHV-7 which may have triggered an atypical presentation of PR. For most people, it resolves without treatment. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. J Eur Acad Dermatol Venereol. Conflicts of Interests: The authors declare there are no competing interests. Disclaimer. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Pityriasis rosea as a cutaneous manifestation of COVID19 infection Would you like email updates of new search results? The study said the appearance was similar to pityriasis rosea, a common skin condition. Chanprapaph K, Pomsoong C, Tankunakorn J, Eden C, Suchonwanit P, Rutnin S. Comparative analyses of clinical features, histopathology, and CD123 immunohistochemistry of oral lupus erythematosus, lichen planus, and other lichenoid lesions. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination. sharing sensitive information, make sure youre on a federal eCollection 2022. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411. JAAD Case Rep 2018; 4: 800801. sharing sensitive information, make sure youre on a federal doi: 10.1111/dth.15601. Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. Figure 1. Disclaimer. . Kroumpouzos G, Paroikaki ME, Yumeen S, Bhargava S, Mylonakis E. Microorganisms. Anyone can get pityriasis rosea. PR is a rare cutaneous reaction after mRNA vaccination against SARS-CoV-2. Br J Dermatol 2021. Rashes can be a better sign of having Covid-19 than fever or - mirror Physical examination revealed that lesions were distributed along cleavage lines, similar to PR, without herald patch or prominent scales (Figure 1C). Epub 2022 Jun 26. -, Welsh E, Cardenas-de la Garza JA, Cuellar-Barboza A, Franco-Marquez R, Arvizu-Rivera RI. 2021;184(6):11941195. Clipboard, Search History, and several other advanced features are temporarily unavailable. Clinical aspect of the lesions after 7days of treatment. Parakeratosis with minimal acanthosis and spongiosis of the epidermis. Disclaimer. However, if it does, the symptoms may last for a longer period. World J Clin Cases. You may be more likely to develop it if youre: In some cases, people with pityriasis rosea report that they had significant or long-term stress before developing a rash. COVID-19 has been reported as one such viral trigger for PR. As King notes, there have been some reported cases of pityriasis rosea occurring in patients after receiving certain vaccines, like the flu shot. Due to the rising incidence of coronavirus disease 2019 (COVID-19) worldwide, mass vaccination has been the cornerstone in preventing viral spread and decreasing morbidity and mortality. A 3-cm oval plaque with peripheral scale, larger than the other lesions, was present on the inferior portion of the right breast. Temiz SA, Abdelmaksoud A, Dursun R, Durmaz K, Sadoughifar R, Hasan A. J Cosmet Dermatol. 7 Articles, This article is part of the Research Topic, Creative Commons Attribution License (CC BY), Division of Dermatology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Adverse cutaneous reactions following COVID-19 vaccines have increased, highlighting not only how SARS-CoV-2 infection but also COVID-19 vaccines may induce adverse cutaneous manifestations. Authors Elina Khattab 1 , Eirini Christaki 2 , Constantinos Pitsios 1 Affiliations 1 Medical School, University of Cyprus, Nicosia, Cyprus. I also had to stop working out and hiking for about a week, as Alexiades is right excessive perspiration worsened the itch. Pityriasis rosea Gibert is an erythematous-papulosquamous dermatosis that frequently occurs in young adults. 2021;35(8):e489e491. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. Cutis. You may develop a raised, discolored, circular or oval-shaped patch that ranges from 1 to 6 centimeters (cm). Lasers Med Sci. Ciccarese G, Parodi A, Drago F. SARS-CoV-2 as possible inducer of viral reactivations. In approximately 50% of people with pityriasis rosea, the patches itch. Careers. government site. and transmitted securely. Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis. doi: 10.1007/s10103-019-02783-8, 16. The https:// ensures that you are connecting to the Pityriasis Lichenoides. Khalili M, Abtahi-Naeini B, Rastegarnasab F, Afshar K. Clin Case Rep. 2022 Jul 19;10(7):e6096. To the best of our knowledge, there have been no reports of PR-like eruptions following inoculation with Oxford/AstraZeneca ChAdOx1 nCoV-19 (AZD1222) vaccine. An official website of the United States government. Clipboard, Search History, and several other advanced features are temporarily unavailable. 2022 Sep;21(9):3692-3703. doi: 10.1111/jocd.15209. JAAD Case Rep. (2018) 4:8001. Safety and efficacy of the BNT162b2 mRNA Covid19 vaccine. Blood tests to check for causes of a rash that arent related to pityriasis rosea. Would you like email updates of new search results? 2021;185(2):e34. All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. A team of researchers . Unable to load your collection due to an error, Unable to load your delegates due to an error. American Academy of Dermatology's National Library of Dermatologic Teaching Slides. official website and that any information you provide is encrypted Epub 2021 Aug 26. 2021 Sep;35(9):e546-e548. Its important to pay attention to your skin. Dermatol Ther. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. Dermatol Online J. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine. 2022 Jun;7:164-168. doi: 10.1016/j.jdin.2022.01.009. Busto-Leis JM, Servera-Negre G, Mayor-Ibarguren A, Sendagorta-Cuds E, Feito-Rodrguez M, Nuo-Gonzlez A, et al. J Eur Acad Dermatol Venereol. These findings were consistent with a diagnosis of PR-like eruption. Br J Dermatol. KL drafted the original manuscript. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review. J Am Acad Dermatol. Some people see the rash disappear within 6 to 8 weeks, but it can take 5 months or longer for the skin to clear. The authors have no conflicts of interests to disclose. Some treatments can alleviate related symptoms, including itching. You also wont have permanent scarring or other damage to your skin. Epub 2021 Apr 26. Authors B M Cyrenne 1 , F Al-Mohammedi 1 , J G DeKoven 1 , R Alhusayen 1 Affiliation Skin lesions appeared in a 49-year-old female 8 days after the first dose of the BNT162b2 mRNA vaccine and in a 53-year-old male 7 days after the second dose of the same vaccine. The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s. eCollection 2022 Feb. Kroumpouzos G, Paroikaki ME, Yumeen S, Bhargava S, Mylonakis E. Microorganisms. Epub 2021 May 29. The following self-care tips may help relieve the discomfort of pityriasis rosea: Take nonprescription allergy medicine (antihistamines), such as diphenhydramine (Benadryl, others). doi: 10.1016/j.jdcr.2018.04.002, 12. Bookshelf The average time between vaccination and rash onset is 10 days, and most patients experience pruritus (70%). Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature. JAAD Case Rep. 2021;7:9394. At first, I thought it could be a fungal infection like ringworm, a common misdiagnosis, says Hartman, but my dermatologist ruled that out when I mentioned the additional spots erupting on my back via our video chat. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Epub 2021 Jun 10. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. See this image and copyright information in PMC. Would you like email updates of new search results? Pityriasis rosea is a benign inflammatory rash that starts with a single red rash, also known as the "herald patch," which eventually gives way to a larger, similar-looking rash on the trunk within days or weeks, says dermatologist Corey L. Hartman, founder of Skin Wellness Dermatology in Birmingham, Alabama. Atypical pityriasis rosea associated with mRNA COVID19 vaccine E. Bostan, Adam Jarbou Published 29 September 2021 Medicine Journal of Medical Virology Variable dermatological manifestations including acral erythema, urticaria, vasculitis, vesicular or pustular eruptions, maculopapular rash have all been reported during the course of Covid-19. The herald patch is the telltale sign that your rash could be PR, but there are other common (though not universal) symptoms as well. Europe PMC is an archive of life sciences journal literature. Pityriasis rosea developing after COVID19 vaccination Cutis. Please enable it to take advantage of the complete set of features! When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic review. doi: 10.1002/ccr3.6096. J Eur Acad Dermatol Venereol 2016; 30: 544545. Histopathological Patterns of Cutaneous Adverse Reaction to Anti-SARS-CoV-2 Vaccines: The Integrative Role of Skin Biopsy. Oily fish, such as mackerel, salmon or sardines. Bookshelf The .gov means its official. (No.) -, Neoh CY, Tan AW, Mohamed K, et al. The https:// ensures that you are connecting to the Previously, PR has been reported in temporal association with various viral inoculations. Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2. Pityriasis rosea following SARS-CoV-2 vaccination: A case series. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine Here, we described a case of PR-like eruption that developed 14 days after Oxford/AstraZeneca vaccination in a 52-year-old Thai woman with glioblastoma. 1 Several vaccines have been developed to fight against COVID19, to prevent the transmission among susceptible individuals and to decrease the morbidity government site. The papulovesicular and pityriasis rosea . (2016) 30:5445. A case of Herpes Zoster Ophtalmicus after third dose of Comirnaty Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine J Eur Acad Dermatol Venereol. Pityriasis rosea. Our expert physicians and surgeons provide a full range of dermatologic, reconstructive and aesthetic treatments options at Cleveland Clinic. Dermatol Ther. 2005;124(6):12341240. Unauthorized use of these marks is strictly prohibited. The most commonly reported features . eCollection 2022 Jul. Temiz SA, Abdelmaksoud A, Dursun R, Durmaz K, Sadoughifar R, Hasan A. J Cosmet Dermatol. Front. Epub 2021 Aug 7. In: Papadakis MA, McPhee SJ, Bernstein J., eds. This site needs JavaScript to work properly. Federal government websites often end in .gov or .mil. Due to the rising incidence of coronavirus disease 2019 (COVID-19) worldwide, mass vaccination has been the cornerstone in preventing viral spread and decreasing morbidity and mortality. 2022 Oct;123:58-69. doi: 10.1016/j.ijid.2022.06.037. (2020) 33:e13650. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. Pityriasis rosea is a common condition that causes discolored patches on your skin. Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection. 2023 Feb 9;11(2):397. doi: 10.3390/vaccines11020397. (2017) 5:20311. The site is secure. Unauthorized use of these marks is strictly prohibited. Children often get infected when someone sneezes or kisses them. J Eur Acad Dermatol Venereol 2020;34:e4367. Herald patch in the right hypochondrium followed by typical oval-shaped secondary plaques, Pityriasis rosea lesions on the upper extremities, MeSH Pityriasis rosea (PR)-like eruption is a cutaneous complication associated with several medications and vaccinations. 2020 Sep 25;155(6):273. doi: 10.1016/j.medcli.2020.05.024. 2022 Feb 3;9 (2):003164. doi: 10.12890/2022_003164. government site. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine. HHS Vulnerability Disclosure, Help "Covid arm," a red, rashlike skin reaction that can occur at the injection site days after inoculation, has been well-publicized. Careers. Skin lesions appeared in a 49-year-old female 8 days after the first dose of the BNT162b2 mRNA vaccine and in a 53-year-old male 7 days after the second dose of the same . eCollection 2022. Martora F, Battista T, Marasca C, Genco L, Fabbrocini G, Potestio L. Clin Cosmet Investig Dermatol. 2022 May;121(5):1003-1007. doi: 10.1016/j.jfma.2021.12.028. This site needs JavaScript to work properly. FOIA doi: 10.1111/jdv.17342. National Library of Medicine Drago F, Ciccarese G, Rebora A, et al. Women are 50% more likely to develop pityriasis rosea. Pityriasis rosea-like rash after messenger RNA COVID-19 - PubMed If you have pityriasis rosea, it can generally be well-managed without any treatment. However, adverse effects to COVID-19 vaccines, particularly cutaneous reactions, have been reported. Another skin condition identified in the study were "vesicular eruptions" seen in 9 per cent of cases. Pityriasis rosea-like eruption presenting as multiple discrete erythematous oval patches and plaques on the back (A) lower abdomen, and bilateral upper thighs (B); lesions distributed along cleavage lines without prominent scales (C). MeSH ", Though there's no single-known cause, King says, "pityriasis rosea is associated with reactivation of herpesviruses 6 and 7 [HHV-6 and HHV-7, respectively], which cause the primary rash, roseola, in infants. . Dermatol Ther. The site is secure. Dos Santos PG, Vieira HCVS, Wietholter V, Gallina JP, Andrade TR, Marinowic DR, Zanirati GG, da Costa JC. Pityriasis rosea is a benign inflammatory rash that starts with a single red rash, also known as the "herald patch," which eventually gives way to a larger, similar-looking rash on the trunk. Most of the rare, severe allergic reactions to these vaccines have occurred in people with a history of allergies. It may appear on any part of your body, but it usually appears on the trunk (torso), arms and legs. Br J Dermatol 2020; 183: 431442. Clinical findings of pityriasis rosealike, Clinical findings of pityriasis rosealike eruption in the patients. This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination. 78 PDF Pityriasis rosea following CoronaVac COVID19 vaccination: a case report Elin Akda, N. Ilter, B. t, . Erdem Pityriasis rosea: An update on etiopathogenesis and management of difficult aspects. If you need help purchasing a product directly from Allure, go to our FAQ. Accessibility McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. A virus may cause pityriasis rosea, but experts arent sure. Allergy Asthma Proc. The patches may itch. Although histopathologic characteristics of PR are also observed in PR-like lesions, the presence of dyskeratotic keratinocytes, interface dermatitis, and eosinophilic infiltration in the dermis may be more prominent in PR-like eruptions (11). KL and KP collated resources. J Med Virol 2021; 93: 1850-1851. 8 PDF Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases D. McMahon, E. Amerson, +11 authors E. Freeman Medicine The patient presented to the Department of Dermatology for a 3 week duration of an extremely pruritic erythematous-squamous lesion, initially on the trunk and upper limbs, with extension to the lower limbs in the last week and the lesion respected the cephalic extremity, palms, and soles. Pityriasis Lichenoides - Dermatologic Disorders - Merck Manuals The transformation will take your breath away. 2021 Aug;185(2):e34. Keywords: Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. However, if you experience any symptoms, therapy can provide relief. Most people with the rash are 10 to 35 years of age. An official website of the United States government. Though pityriasis rosea is a common skin rash, it can still make you feel self-conscious, and it can be unpleasant if it itches. The site is secure. Epub 2022 Jan 5. 2022 Aug 11;9(8):43. doi: 10.3390/medicines9080043. HHS Vulnerability Disclosure, Help Unable to load your collection due to an error, Unable to load your delegates due to an error. Cutaneous manifestation has been reported in 0.2% of patients infected by COVID-19 in China, and 18 out of 88 patients from Italy. Treatment with topical 0.1% triamcinolone acetonide twice per day showed partial response after seven days. (d) Patient 2: Closeup of plaques, with the hyperpigmented centre and trailing scale. For most people, it resolves without treatment. Here, we report the first case of PR-like eruption following ChAdOx1 nCoV-19 (Oxford/AstraZeneca) vaccination. Bethesda, MD 20894, Web Policies Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID19: a preliminary review of an emerging issue. Pityriasis lichenoides has distinct acute and chronic forms, which are usually distinct . 2022 Dec;9:127. doi: 10.1016/j.jdin.2022.03.018. According to King, an in-person skin exam is usually enough to make an accurate diagnosis, though a biopsy or blood work may be necessary for some. Pityriasis is linked mainly with herpesviruses 6 and 7; only a . J Med Virol. One case of pityriasis rosea is reported in a patient infected with COVID-19, and the most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute hemorrhagic edema of infancy. Pityriasis rosea-like eruptions following vaccination with BNT162b2 Int J Infect Dis. Your Random Rash Could Be Pityriasis Rosea - Yahoo! Washrawirul C, Triwatcharikorn J, Phannajit J, Ullman M, Susantitaphong P, Rerknimitr P. J Eur Acad Dermatol Venereol. Adya KA, Inamadar AC, Albadri W. Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male. Drago F, Ciccarese G, Javor S, et al. Among the common cutaneous manifestations of COVID-19 (e.g., morbilliform eruptions, chilblains, and varicella-like vesicles), PR and PR-like eruptions have rarely been described (6, 7). FOIA Medicines (Basel). Epub 2020 Jun 29. Indian J Dermatol 2016;61:37584. -, Mahajan K, Relhan V, Relhan AK, et al. We present two cases of COVID-19 vaccine-induced pityriasis rosea. 9500 Euclid Avenue, Cleveland, Ohio 44195 |, Important Updates + Notice of Vendor Data Event. doi: 10.1111/bjd.20143. The .gov means its official. Accessibility (a) Patient 1: Thin, Histopathological findings of pityriasis rosealike, Histopathological findings of pityriasis rosealike eruption in patient 1. While unusual, one patient developed pityriasis rosea once a year for five years in a row. An official website of the United States government. Copyright 2021 the Author(s). 2021 Sep;60(9):1150-1151.doi: 10.1111/ijd.15700. What at-home treatments do you recommend? Pityriasis rosea isnt a sexually transmitted disease or infection (STD or STI). 2021 Aug;35(8):e491-e493. Some people develop a few large patches on their skin. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. COVID-19; HHV, human herpes virus; Moderna; PR; PR, pityriasis rosea; PR-LE; PR-LE, pityriasis rosea-like eruption; Pfizer; coronavirus; dermatology; mRNA vaccine; mRNA, messenger RNA; pityriasis rosea; pityriasis rosealike eruption; vaccine. Dtsch Arztebl Int. Pityriasis rosea usually resolves on its own without treatment in most cases, King says, but topical corticosteroids can be used for itchy control if necessary, which is what I used. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291919/). Influenza viruses and vaccines have triggered pityriasis rosea in some cases.". Numerous scattered erythematous plaques with fine scale oriented along skin cleavage, Herald patch of pityriasis rosea. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination. At first, I thought it was a mosquito bite. 9 , 10 These findings suggest that immuneinduced viral reactivation - rather than Pityriasis rosea: Diagnosis and treatment - American Academy of Dermatology Pityriasis rosea following SARS-CoV-2 vaccination: A case series. Moreover, central dusky-red erythematous was observed on some plaques (Figure 2A). N Engl J Med 2020; 383: 2603-2615. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection Lawley LP, McCall CO, Lawley TJ. Histopathologic features: (B) microscopic image at a low power field showing psoriasiform epidermal hyperplasia, perivascular infiltration, and interface dermatitis (hematoxylin-eosin; scale bar represents 100 m); (C) microscopic image at a high power field showing focal spongiotic dermatitis, interface dermatitis, and perivascular infiltration of lymphocytes and eosinophils (hematoxylin-eosin; scale bar represents 40 m). Women and young people are most likely to have these reactions. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A Epub 2020 Nov 20. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Unauthorized use of these marks is strictly prohibited. A woman. Careers. Epub 2022 Jan 5. The authors suggest more research is necessary. Pityriasis Rosea Induced by COVID preview & related info | Mendeley 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. 2021 Jun 25;118(25):431. doi: 10.3238/arztebl.m2021.0257. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Despite this rare complication, our report highlights that the presence of PR-like eruption is not a contraindication for subsequent vaccinations. PMC Luckily, it's not contagious. It is likely that a new viral trigger of pityriasis rosea is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). sharing sensitive information, make sure youre on a federal While you don't need to treat the rash, some patients ask for treatment to take care of the following. Epub 2022 Feb 9. 2022 Oct 4;15:2117-2127. doi: 10.2147/CCID.S371630. Epub 2022 Feb 9. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. Studies show that some skin conditions may appear with COVID-19, including pityriasis rosea. eCollection 2022. Histopathological findings of pityriasis rosealike eruption in patient 1. Fortunately, PR-like eruption is responsive to topical corticosteroids without any systemic adverse effects. Figure 3. Healthcare experts believe herpesvirus 6 (HHV-6), HHV-7 and/or HHV-8 cause pityriasis rosea, but there arent any conclusive studies. The site is secure. Bookshelf Even though it is benign, it can cause substantial. "Other treatments including phototherapy or oral medications can be considered for extensive or persistent cases, [and] some small case studies support the use of oral antivirals like acyclovir or oral anti-inflammatory antibiotics erythromycin," King explains. However, in cases of atypical PR, it may present with erythema multiforme-like lesions and purpura (5). We present two cases of COVID-19 vaccine-induced pityriasis rosea. (Unfortunately, I scratched my rash until it bled, so my hyperpigmentation may linger.). Moreover, COVID-19 may solely induce human herpesvirus reactivation through the immunomodulatory ability of SARS-CoV-2 to reactivate latent viruses (8, 9). One case of pityriasis rosea is reported in a patient infected with COVID-19, and the most commonly reported features are exanthomatous rash, urticaria, chickenpox like vesicles, petechiae, and acute hemorrhagic edema of infancy. Unable to load your collection due to an error, Unable to load your delegates due to an error. -, Carballido Vzquez A.M., Morgado B. Pityriasis rosea-like eruption after Pfizer-BioNTech COVID-19 vaccination. In conclusion, we have described the first case of PR-like eruption following ChAdOx1 nCoV-19 (Oxford/AstraZeneca) vaccination. The .gov means its official. Accessibility 2022 May;11(2):222-225. doi: 10.7774/cevr.2022.11.2.222. Pityriasis Rosea Induced by COVID-19 Vaccination - PubMed Among patients who received inactivated vaccines, another case of PR-like eruption was reported four days after the first dose of CoronaVac (SinoVac) (1). 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Despite this rare complication, our report highlights that the presence of PR-like eruption is not a contraindication for subsequent vaccinations. (2006) 12:1. doi: 10.5070/D380D8301D, 11. Due to the temporal relationship between vaccination and onset of rash, COVID-19 vaccination was the most likely etiology. and transmitted securely. Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: Lessons learned from current evidence.